Form 4 holding
CEO & President, ImprimisRx
HARROW, INC.
- Security class
- Common Stock
- Shares / value
- 467,388
- Estimated value
- $10,791,989
- Report date
- 07 Apr 2025
- Price
- $23.09
- Ownership
- Direct
John P. Saharek - CEO & President, ImprimisRx at HARROW, INC.
Issuer-level insider activity
- Role
- CEO & President, ImprimisRx
- Issuer symbol
- HROW on Nasdaq
- Entity type
- Individual
- Source evidence
- Open source filing history
Identity
1 identity field
SEC evidence
1 source field
No buys or sells have been reported by John P. Saharek since 01 Jun 2025
Reported holdings for John P. Saharek in HARROW, INC.
Form 4 holding
CEO & President, ImprimisRx
HARROW, INC.
- Security class
- Performance Stock Unit
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 03 Apr 2025
- Price
- $23.09
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CEO & President, ImprimisRx
HARROW, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 11 Sep 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for John P. Saharek in HARROW, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.